Results 11 to 20 of about 76,100 (290)

Editorial: Epidemiology of Atypical Demyelinating Diseases [PDF]

Frontiers in Neurology, 2021
Dalia Rotstein, Dalia Rotstein, Su-Hyun Kim, Yael Hacohen, Michael Levy   +4 more
doaj   +2 more sources

T cell approach to demyelinating diseases [PDF]

Springer Seminars in Immunopathology, 1985
Hartmut Wekerle, Walter Fierz
openalex   +5 more sources

Myelin oligodendrocyte glycoprotein antibody-associated disorders: clinical spectrum, diagnostic evaluation, and treatment options [PDF]

Clinical and Experimental Pediatrics, 2021
Inflammatory or immune-mediated demyelinating central nervous system (CNS) syndromes include a broad spectrum of clinical phenotype and different overlapping diseases.
Yun-Jin Lee, Sang Ook Nam, Ara Ko, JuHyun Kong, Shin Yun Byun   +4 more
doaj   +1 more source

Brainstem syndrome at onset is related to an early MS diagnosis in Peru: A national referral center cohort

Heliyon, 2021
Background: MS is unpredictable regarding clinical symptoms; however, certain symptoms represent the preferred localization of white matter lesions such as brainstem, spinal cord; or optic nerve.
César Caparó-Zamalloa, Sheila Castro-Suarez, Jaqueline Cortez-Escalante, Wilfor Aguirre-Quispe, Erik Guevara-Silva, Victor Osorio-Marcatinco, María Meza-Vega   +6 more
doaj   +1 more source

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases

Frontiers in Neurology, 2022
Tumefactive demyelinating lesions (TDL) represent a diagnostic dilemma for clinicians, and in rare atypical cases a collaboration of a neuroradiologist, a neurologist, and a neuropathologist is warranted for accurate diagnosis.
Aigli G. Vakrakou, Maria-Evgenia Brinia, Ioanna Svolaki, Theodore Argyrakos, Leonidas Stefanis, Constantinos Kilidireas   +5 more
doaj   +1 more source

Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs

Clinical Immunology Communications, 2023
We analyzed immune response to SARS-CoV-2 vaccination by measuring specific IgG titers and T-cell reactivity to different SARS-CoV-2 peptides in multiple sclerosis patients taking different disease-modifying treatments.
Virginia Meca-Lallana, Laura Esparcia-Pinedo, Clara Aguirre, Carolina Díaz-Pérez, Ainhoa Gutierrez-Cobos, Mónica Sobrado, Estefanía Carabajal, Beatriz del Río, Noelia Ropero, Ramón Villagrasa, José Vivancos, Francisco Sanchez-Madrid, Arantzazu Alfranca   +12 more
doaj   +1 more source

Tracking the impact of multiple sclerosis on employment status: the development of a questionnaire

Arquivos de Neuro-Psiquiatria, 2022
Background Multiple sclerosis (MS) has a negative effect on employment status.
Evangelina Valeria Cores, Judith Steinberg, Carolina Cuesta, María Celeste Curbelo, Mabel Alicia Osorio, Johana Julia Bauer, Daniel Gustavo Politis   +6 more
doaj   +1 more source

Features of multiple sclerosis in childhood in the Republic of Tatarstan

Неврология, нейропсихиатрия, психосоматика, 2023
Multiple sclerosis (MS) in children and adolescents is a genuine concern of pediatric neurology that specialists in all countries are dealing with. To date, neither the causes of onset nor the individual components of the pathogenesis of the disease have
A. R. Khaibullina, F. A. Khabirov, T. I. Khaibullin   +2 more
doaj   +1 more source

Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis

Frontiers in Immunology, 2023
Current understanding of Multiple Sclerosis (MS) pathophysiology implicates perturbations in adaptive cellular immune responses, predominantly T cells, in Relapsing-Remitting forms (RRMS).
Aigli G. Vakrakou, Aigli G. Vakrakou, Nikolaos Paschalidis, Eleftherios Pavlos, Eleftherios Pavlos, Christina Giannouli, Dimitris Karathanasis, Xristina Tsipota, Georgios Velonakis, Christine Stadelmann-Nessler, Maria-Eleftheria Evangelopoulos, Leonidas Stefanis, Constantinos Kilidireas, Constantinos Kilidireas   +13 more
doaj   +1 more source

Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature

Frontiers in Neurology, 2020
Atypical forms of demyelinating diseases with tumor-like lesions and aggressive course represent a diagnostic and therapeutic challenge for neurologists.
Aigli G. Vakrakou, Dimitrios Tzanetakos, Theodore Argyrakos, Georgios Koutsis, Maria-Eleptheria Evangelopoulos, Elisabeth Andreadou, Maria Anagnostouli, Marianthi Breza, John S. Tzartos, Elias Gialafos, Antonios N. Dimitrakopoulos, Georgios Velonakis, Panagiotis Toulas, Leonidas Stefanis, Constantinos Kilidireas   +14 more
doaj   +1 more source